Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -196,039 | -76,422 | -143,099 | -165,291 | -124,088 |
| Depreciation Amortization | 10,432 | 4,205 | -2,754 | 608 | 3,129 |
| Accounts receivable | 4,588 | -3,804 | 20,124 | -5,084 | -9,616 |
| Accounts payable and accrued liabilities | -1,104 | 1,984 | 350 | 1,170 | -2,847 |
| Other Working Capital | 28,272 | -302 | 31,421 | -19,989 | -23,189 |
| Other Operating Activity | 78,482 | -53,147 | 1,235 | 39,032 | 49,495 |
| Operating Cash Flow | $-75,369 | $-127,486 | $-92,723 | $-149,554 | $-107,116 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -142 | N/A | -118 | -212 |
| Purchase Of Investment | N/A | -58,822 | -159,151 | -226,016 | -45,228 |
| Sale Of Investment | 43,378 | 154,437 | 167,091 | 121,878 | 192,780 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -5,500 |
| Investing Cash Flow | $43,378 | $95,473 | $7,940 | $-104,256 | $141,840 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 27,250 | 83,300 | N/A | N/A | N/A |
| Debt Repayment | -250 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 9,511 | 1,452 | 1,124 | 193,738 | 13,648 |
| Other Financing Activity | -6,463 | -43,106 | 0 | 0 | 60,000 |
| Financing Cash Flow | $30,048 | $41,646 | $1,124 | $193,738 | $73,648 |
| Exchange Rate Effect | 20 | -11 | -34 | -488 | -48 |
| Beginning Cash Position | 62,814 | 53,192 | 136,885 | 197,445 | 89,121 |
| End Cash Position | 60,891 | 62,814 | 53,192 | 136,885 | 197,445 |
| Net Cash Flow | $-1,923 | $9,622 | $-83,693 | $-60,560 | $108,324 |
| Free Cash Flow | |||||
| Operating Cash Flow | -75,369 | -127,486 | -92,723 | -149,554 | -107,116 |
| Capital Expenditure | N/A | -142 | N/A | -118 | -212 |
| Free Cash Flow | -75,369 | -127,628 | -92,723 | -149,672 | -107,328 |